These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 20818789)

  • 41. Associations of Green Tea Consumption and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Pathology in Cognitively Intact Older Adults: The CABLE Study.
    Ma YH; Wu JH; Xu W; Shen XN; Wang HF; Hou XH; Cao XP; Bi YL; Dong Q; Feng L; Tan L; Yu JT
    J Alzheimers Dis; 2020; 77(1):411-421. PubMed ID: 32804140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.
    Koychev I; Gunn RN; Firouzian A; Lawson J; Zamboni G; Ridha B; Sahakian BJ; Rowe JB; Thomas A; Rochester L; Ffytche D; Howard R; Zetterberg H; MacKay C; Lovestone S;
    J Alzheimers Dis; 2017; 60(1):283-293. PubMed ID: 28800330
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Florbetapir positron emission tomography and cerebrospinal fluid biomarkers.
    Hake A; Trzepacz PT; Wang S; Yu P; Case M; Hochstetler H; Witte MM; Degenhardt EK; Dean RA;
    Alzheimers Dement; 2015 Aug; 11(8):986-93. PubMed ID: 25916563
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cardiorespiratory Fitness Attenuates the Influence of Amyloid on Cognition.
    Schultz SA; Boots EA; Almeida RP; Oh JM; Einerson J; Korcarz CE; Edwards DF; Koscik RL; Dowling MN; Gallagher CL; Bendlin BB; Christian BT; Zetterberg H; Blennow K; Carlsson CM; Asthana S; Hermann BP; Sager MA; Johnson SC; Stein JH; Okonkwo OC
    J Int Neuropsychol Soc; 2015 Nov; 21(10):841-50. PubMed ID: 26581795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pittsburgh compound-B and Alzheimer's disease biomarkers in CSF, plasma and urine: An exploratory study.
    Degerman Gunnarsson M; Lindau M; Wall A; Blennow K; Darreh-Shori T; Basu S; Nordberg A; Larsson A; Lannfelt L; Basun H; Kilander L
    Dement Geriatr Cogn Disord; 2010; 29(3):204-12. PubMed ID: 20332638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta amyloid in Alzheimer's disease: increased deposition in brain is reflected in reduced concentration in cerebrospinal fluid.
    Grimmer T; Riemenschneider M; Förstl H; Henriksen G; Klunk WE; Mathis CA; Shiga T; Wester HJ; Kurz A; Drzezga A
    Biol Psychiatry; 2009 Jun; 65(11):927-34. PubMed ID: 19268916
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease.
    Steen Jensen C; Portelius E; Siersma V; Høgh P; Wermuth L; Blennow K; Zetterberg H; Waldemar G; Gregers Hasselbalch S; Hviid Simonsen A
    Dement Geriatr Cogn Disord; 2016; 42(3-4):146-158. PubMed ID: 27643858
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pittsburgh Compound B and AV-1451 positron emission tomography assessment of molecular pathologies of Alzheimer's disease in progressive supranuclear palsy.
    Whitwell JL; Ahlskog JE; Tosakulwong N; Senjem ML; Spychalla AJ; Petersen RC; Jack CR; Lowe VJ; Josephs KA
    Parkinsonism Relat Disord; 2018 Mar; 48():3-9. PubMed ID: 29254665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alzheimer disease biomarkers, attentional control, and semantic memory retrieval: Synergistic and mediational effects of biomarkers on a sensitive cognitive measure in non-demented older adults.
    Aschenbrenner AJ; Balota DA; Tse CS; Fagan AM; Holtzman DM; Benzinger TL; Morris JC
    Neuropsychology; 2015 May; 29(3):368-81. PubMed ID: 25222200
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Cerebrospinal Fluid Aβ1-42/Aβ1-40 Ratio Improves Concordance with Amyloid-PET for Diagnosing Alzheimer's Disease in a Clinical Setting.
    Niemantsverdriet E; Ottoy J; Somers C; De Roeck E; Struyfs H; Soetewey F; Verhaeghe J; Van den Bossche T; Van Mossevelde S; Goeman J; De Deyn PP; Mariën P; Versijpt J; Sleegers K; Van Broeckhoven C; Wyffels L; Albert A; Ceyssens S; Stroobants S; Staelens S; Bjerke M; Engelborghs S
    J Alzheimers Dis; 2017; 60(2):561-576. PubMed ID: 28869470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stage-dependent agreement between cerebrospinal fluid proteins and FDG-PET findings in Alzheimer's disease.
    Yakushev I; Muller MJ; Buchholz HG; Lang U; Rossmann H; Hampel H; Schreckenberger M; Fellgiebel A
    Curr Alzheimer Res; 2012 Feb; 9(2):241-7. PubMed ID: 22044023
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults.
    Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL
    Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Role of family history for Alzheimer biomarker abnormalities in the adult children study.
    Xiong C; Roe CM; Buckles V; Fagan A; Holtzman D; Balota D; Duchek J; Storandt M; Mintun M; Grant E; Snyder AZ; Head D; Benzinger TL; Mettenburg J; Csernansky J; Morris JC
    Arch Neurol; 2011 Oct; 68(10):1313-9. PubMed ID: 21987546
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concordance Between Cerebrospinal Fluid Biomarkers with Alzheimer's Disease Pathology Between Three Independent Assay Platforms.
    Doecke JD; Rembach A; Villemagne VL; Varghese S; Rainey-Smith S; Sarros S; Evered LA; Fowler CJ; Pertile KK; Rumble RL; Trounson B; Taddei K; Laws SM; Macaulay SL; Bush AI; Ellis KA; Martins R; Ames D; Silbert B; Vanderstichele H; Masters CL; Darby DG; Li QX; Collins S;
    J Alzheimers Dis; 2018; 61(1):169-183. PubMed ID: 29171991
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease.
    Hinrichs AL; Mintun MA; Head D; Fagan AM; Holtzman DM; Morris JC; Goate AM
    Biol Psychiatry; 2010 Mar; 67(6):581-3. PubMed ID: 19892322
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic APP mutation carriers.
    Schöll M; Wall A; Thordardottir S; Ferreira D; Bogdanovic N; Långström B; Almkvist O; Graff C; Nordberg A
    Neurology; 2012 Jul; 79(3):229-36. PubMed ID: 22700814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GWAS of cerebrospinal fluid tau levels identifies risk variants for Alzheimer's disease.
    Cruchaga C; Kauwe JS; Harari O; Jin SC; Cai Y; Karch CM; Benitez BA; Jeng AT; Skorupa T; Carrell D; Bertelsen S; Bailey M; McKean D; Shulman JM; De Jager PL; Chibnik L; Bennett DA; Arnold SE; Harold D; Sims R; Gerrish A; Williams J; Van Deerlin VM; Lee VM; Shaw LM; Trojanowski JQ; Haines JL; Mayeux R; Pericak-Vance MA; Farrer LA; Schellenberg GD; Peskind ER; Galasko D; Fagan AM; Holtzman DM; Morris JC; ; ; ; Goate AM
    Neuron; 2013 Apr; 78(2):256-68. PubMed ID: 23562540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.